Before reading the document please note that we do not represent any government agency and nothing in this guide should be taken as fact. The regulations we provide are true to the publishing date. You should check FDA guidelines and regulations for implementing your own electronic signatures.
The following text is taken directly from the Title CFR 21 Part 11 guidelines. The complete regulations can be found on the U.S. Food and Drug Administration (FDA) website.
Before using electronic signatures, or at the time of use, persons using electronic signatures must certify to the Agency the electronic signatures used in their system on or after August 20, 1997, are intended to be the legally binding equivalent of handwritten signatures.
The above-mentioned certifications must be in paper form and signed with handwritten signatures and submitted to ORO/DEIO (HFC-130).
On request, persons must provide additional certification or testimony that a specific electronic signature is the legally binding equivalent of the signer=s handwritten signature.”
Setting up your electronic signatures for the FDA can be an easy process, following our guidelines above can be used as a starting point for your compliance needs. If you would like a demonstration of Version Control to help your compliance with 21 CFR Part 11 for life science organisations operating in GMP/GLP labs, get in touch.